Stophairlossnow

RepliCel Life Sciences is pleased to provide an update on its first-in-human clinical trial TS001-2009.

As of today, all 20 subjects have been enrolled in the study and have provided biopsy samples for processing using the proprietary RepliCel? technology. Furthermore, the first injection of hair follicle cells prepared using RepliCel? technology was completed on March 10, 2011.

The final injections of hair follicle cells are anticipated to take place before the end of July 2011.

The first injection of hair follicle cells represented the beginning of the next stage of the TS001-2009 study. In this stage, the post-injection follow-up period, subjects return to the study centre to have their health closely monitored to ensure that there have been no adverse effects associated with receiving the injections and to determine the hair growth stimulating efficacy of the hair follicle cell injections.

All subjects are expected to complete their six-month follow-up visit by the end of January 2012. Once the final patient has completed their six-month follow-up visit, an interim analysis of all collected data will be performed to assess the primary outcome measure of the TS001-2009 study.

The analysis will involve assessment of the local (at treatment sites) safety profile of autologous hair follicle cells compared to placebo as defined by adverse events (AEs) with respect to their causality, incidence, severity and seriousness.

Complete hair loss article 

Categories: Hair Cloning, Hair Loss

How early you spot your thinning hair determines how much hair you save. If you wait until the hair loss is visible to the naked eye, you're too late – 50 percent is already gone.

National hair restoration expert Alan J. Bauman, M.D., founder and medical director of Bauman Medical Group in Boca Raton, was featured last week on ABC’s Good Morning America, FOX News, and The New York Times discussing the benefits of new procedures and treatment options.

Today, thanks to new technology and medical advancements, hair loss is no longer inevitable – it’s optional.

Latisse for Hair Loss:

Latisse (Bimatoprost) is already FDA approved to grow longer eyelashes. Allergan in currently in phase I clinical trials to use it on male and female pattern hair loss as well. If it succeeds, it will be only the second topical treatment to receive FDA approval for hair loss (the other is Minoxidil/Rogaine). Dr. Bauman is already prescribing Latisse for off-label use on the scalp in some patients and seeing positive results. Both the New York Times and Good Morning America featured Dr. Bauman’s pioneering research with Latisse.

Complete hair loss article 

Categories: Hair Cloning, Hair Loss

Robert Niedbalski, D.O., hair transplant surgeon and medical director at Northwest Hair Restoration in Tacoma, WA, is now offering an advanced treatment for genetic hair loss. The breakthrough hair restoration technique dramatically multiplies the number of hair follicles in an area that has previously stopped growing hair.

Using FDA approved ACell wound healing powder MatriStem® MicroMatrix™ and an arterial blood serum combination, Dr. Niedbalski is able to activate stem cells present in scalp tissue and significantly increase the rate of hair re-growth.

This hair cloning technique was discovered by Dr. Gary Hitzig, a leading hair transplant researcher and surgeon. Dr. Hitzig discovered that MatriStem powder, when dissolved in an arterial blood serum rich in the patient’s own adult stem cells, could be injected into the donor area and top of scalp where hair is being transplanted.

The powder and blood serum combination acted like a hair growth accelerator and fertilizer by activating stem cells present in scalp tissues and motivated healing by duplicating normal tissue and hair follicles instead of forming a scar.

In collaboration with Dr. Hitzig, Dr. Niedbalski is the only hair restoration surgeon in the Pacific Northwest to offer this significant new treatment for hair loss.

Complete hair loss article 

Categories: Hair Cloning, Hair Loss

Q. When did you first learn that you had alopecia?

A. In 1995, a time of big transitions in my life. After doing highly successful postdoctoral research on genetic blistering skin diseases at Jefferson Medical College, I’d arrived here at Columbia to start my own laboratory. I had just turned 30. I was getting a divorce. When you start your first lab, a researcher is expected to find something different from their postdoc work. For my first six months here, I sat thinking, “What am I going to do when I grow up?”

In the midst of all this, I went to a beauty parlor and the stylist said: “What’s happened here? You have a big patch of hair missing from the back of your head.” I ignored that. But the next day at the lab, I asked a colleague to take a look. She let out a bloodcurdling scream: “You have a huge bald spot!”

I immediately went over to the clinic here. They said: “Oh, you have alopecia. There’s not much we can do to treat it.”

Q. Alopecia is genetic. Do you have relatives with it?

A. My mom and her mother had hair loss from a young age. I have a cousin also who lost all of her hair. Ironically, hair is a big part of my family’s life. My grandfather was a barber in Italy and then later in New Jersey. And my mother was a hairdresser before retiring. I’m the first person in my family to go to college and graduate school: Rutgers. My mother now says, “You’re just another hair person — you just do it differently.”

Q. How did this history lead to your research?

A. In the months after my diagnosis, I went through panic and shock. Every morning, I’d wake up wondering if it was all going to fall out. And new spots did show up. I’d cover them with the most careful combing. Then there’d be a new one. It was like plugging holes in a dam. It finally stopped after two years.

Complete hair loss article 

Categories: Alopecia, Female hair loss, Hair Cloning, Hair Loss, Hair Loss Treatment, Womens hair loss

Botox maker Allergan has begun clinical trials of a possible hair-growth treatment based on the active ingredient in its drug Latisse, which stimulates the growth of eyelashes.

Allergan announced late last month on the federal Clinical Trials website that recruiting of volunteer subjects has begun. This phase of the experiments is scheduled to be completed in February.

The website includes a description of what’s required of volunteers and an email address for more information. The experimenters aren’t in a location that’s convenient to Orange County: They are in Tempe, Ariz.

This phase of the trials will include a total of about 28 patients — men with moderate male-pattern baldness and women with moderate female-pattern hair loss.

The FDA approved Latisse in 2008 as a treatment for sparse eyelashes, with a warning that it can cause hair growth on other parts of the body that come in contact with the drug. Some doctors have already tried using Latisse as an “off-label” treatment for hair loss.

Complete hair loss article 

Categories: Baldness, Hair Care, Hair Cloning, Hair Loss, Hair Loss Treatment

Berlin researchers have grown the world’s first hair follicle using stem cells, giving hope to both the bald and animal rights activists around the world

The hair follicle created by bioengineers at the capital’s Technical University (TU) is somewhat thinner than a normal scalp follicle, but will provide both hair implant possibilities and end the need for millions of animal tests in the future, daily Die Welt said.

Created by bioengineer and doctor Roland Lauster and his team, the hair follicle can be used to research the causes of hair loss, and may also be used for more effective implants than hair plugs – after clinical studies, of course.

“Preparations for this are already in motion,” Lauster told Die Welt.

Additional purposes may include research on hair growth, structure and pigmentation, as well as the effects of toxic substances.

Nanoparticles enter the skin through hair follicles, thus the new invention could tap into the enormous cosmetic testing market, which has seen the number of animal experiments explode in recent years, the paper said.

“Since 1950, the development of new chemicals has gone up 500-fold, and so has the number of animal tests for the licensing of these,” Lauster said.

Skin and hair follicles created in a lab could replace the need for test animals, the paper wrote.

The professor plans to team up with Dr. Uwe Marx to establish a hair follicle test system, then move on to creating a miniature liver, kidney and bone marrow to form a multi-organ biochip to test pharmaceutical and cosmetic substances.

Complete hair loss article 

Categories: Baldness, Female hair loss, Hair Care, Hair Cloning, Hair Loss, Hair Loss Treatment

TrichoScience Innovations has developed and patented a non-surgical hair cell restoration procedure based on the clinical replication of hair root cells and their re-introduction into areas of hair loss. The treatment has the potential to become a safe and effective non-surgical treatment for pattern baldness and other forms of hair loss in both men and women.

Developed by Renowned Specialists

The TrichoScience procedure was developed over the past ten years by recognized research scientists and medical experts specializing in the fields of hair growth, hair biology and dermatology. Visit our Medical Team page for more information.

Clinical Trials

The TrichoScience proprietary hair cell replication procedure has shown promising results in laboratory test models. Based on these results, the TrichoScience team has started development of a human clinical trial program. The team is on track to start in Europe on their first-in-human research protocol in the second half of 2010.

Complete hair loss article 

Categories: Baldness, Hair Cloning, Hair Loss

Richfeel Trichology centre, the pioneers of trichology in India, has recently introduced a Hair DX test, in collaboration with Hair DX, U.S.A. This test is a unique way to predict genetic hair loss that will put your anxieties to rest.

Currently diagnostics of hair loss relies on visual observation of hair thinning. When hair thinning is visible one has probably lost about 25% of hair in that area of the scalp.

The Hair DX genetic screening test helps in assessing the risk of hair loss and provides an opportunity for early medical intervention prior to visible signs of hair loss. In simple word, first time in India, a genetic test that could indicate if baldness (HAIR LOSS) is in the GENES and if so it can be delay it up to 25 years with the use of Richfeel’s hair care treatments and products.

Hair DX test is conducted in a needle less and pain less manner. The test is done just with the help of a sample of saliva with a cotton swab from the mouth. This test can be conducted on males and females from 18 years of age or older who are concerned about hair loss. This unique test is conducted at Richfeel Trichology centers in Mumbai, Pune, Delhi and Chandigarh.

Complete hair loss article 

Categories: Hair Care, Hair Cloning, Hair Loss, Hair Loss Treatment